|
Links
|
| |
The ACRF Centre for Therapeutic Target Discovery created on the Royal Melbourne
Hospital Parkville Campus has resulted from growing recognition of the need for an
integrated approach to cancer service delivery and basic, translational and clinical research.
The consortium that launched the initial phase of the MCCC includes the Royal Melbourne
Hospital (Melbourne Health), Royal Women's Hospital, The Ludwig Institute for Cancer
Research (Parkville campus), The Walter and Eliza Hall Institute of Medical Research, and The
University of Melbourne. |
|
Melbourne Health is a major public health provider in Victoria, Australia, including The
Royal Melbourne Hospital. It provides comprehensive acute, sub-acute and community based
health care programs to about one-third of metropolitan Melbourne's population, as
well as general and specialist services to regional and rural Victorians and statewide services.
The Clinical Haematology and Medical Oncology service has an international reputation for
the treatment of patients with cancers and haematological diseases including leukaemia
and lymphoma.
|
|
The Royal Women's Hospital is Australia’s largest specialist tertiary hospital which has been dedicated to improving the health of women and newborn babies for over 150 years. We provide clinical leadership and expertise across the areas of oncology, gynaecology, mental health, maternity, neonatal and intensive care, child care, health promotion and other women’s services. We are committed to quality and safety in patient care and we promote a learning culture that provides workplace education and support for our medical, nursing, midwifery and allied health staff in particular. Informed by research the Women’s is continually looking for new ways to improve the health outcomes of all women and newborn babies. |
|
The Ludwig Institute for Cancer Research (LICR) is the largest international non-profit
Institute dedicated to understanding and controlling cancer. It comprises a worldwide
network of nine branches in seven countries dedicated to basic and clinical cancer research.
LICR is distinguishable from other cancer research institutes by its size and global reach, and
the fact that it takes responsibility for the entire discovery continuum from the laboratory to
the clinic.
|
|
The Walter and Eliza Hall Institute of Medical Research (WEHI) is one of Australia's foremost
medical research establishments, its mission being "mastery of disease through discovery".
Over many decades, advances and discoveries at the Institute have led to significant benefits
for patients throughout the world. WEHI scientists are attempting to understand the
underlying causes of many diseases, in order to develop better treatments. Prime targets include cancer (leukemia, lymphoma and breast cancer), autoimmune diseases (juvenile diabetes, rheumatoid arthritis and coeliac disease) and infectious diseases (malaria and leishmaniasis).
|
|
The Faculty of Medicine, Dentistry and Health Sciences is Australia's premier biomedical
research faculty. Biomedicine at the University of Melbourne is ranked no. 1 in Australia and
no. 10 in the world (Times Higher Education Supplement rankings of universities, November
2005). Its research goal is to improve understanding and treatment of human disease.
|
|
The Australian Cancer Research Foundation (ACRF) is dedicated to helping find a cure for
cancer through the continued support of world-class research in Australia. Established in
1984 by the late Sir Peter Abeles, the Foundation has evolved into one of Australia's leading
not-for-profit organisations. In 20 years they have raised over $40 million to support leading
edge Australian research initiatives, ensuring the country remains at the forefront of global
cancer research.
|
|
|
|
|
|
The ACRF Centre for Therapeutic Target Discovery
was launched by a generous donation from the ACRF in 2006.
|
|
|
|
|
